Skip to main content
Canadian Consortium of Investigation of Cannabinoids

Canadian Consortium of Investigation of Cannabinoids (4)

"The CCIC is a federally registered Canadian nonprofit organization of basic and clinical researchers, health care professionals and educators that promotes research and evidence-based education concerning the endocannabinoid system, the therapeutic applications of cannabinoids, the potential harms associated with cannabis use and the health and societal impacts of non-medical cannabis use."

 
Why is cannabis research so much harder than researching other medicines? Lauren Kelly PhD is an Associate Professor at the University of Manitoba, Cannabis researcher and Trialist, CCIC President, and CMCN Co-Lead, she joins Reefer MEDness to explain why cannabis clinical trials face unique barriers in Canada. Learn how Health Canada regulations, GMP vs GPP standards, product consistency challenges, and gaps in the Cannabis Act affect research, patient care, and evidence generation. Discover why researchers often can't study the same cannabis products patients actually use, how clinical trials begin from real-world observations, and what Canada can do to become a global leader in cannabis science. Listen now to understand the hidden challenges behind cannabis research and the future of evidence-based medical cannabis.

Can medical cannabis help children—and what does the evidence actually show? Pediatric pharmacologist, Dr. Lauren Kelly, joins Trevor and Kirk to discuss medical cannabis in children. This wide ranging conversation includes discussion about epilepsy, autism, pediatric oncology, and the unique challenges of studying cannabinoids during development. Learn what researchers know about CBD, THC & kids, why evidence remains relatively limited, and how stigma, policy, and education continue to affect patient care. Listen now for an evidence-based discussion on pediatric cannabis research, safety, and the future of cannabinoid medicine for children.

Canadians are changing their perspective of cannabis. People are using it as medicine and access has never been easier. Why is this bad? Why should anyone care how we access our medicinal cannabis? Canada is one of the few countries with federally legal cannabis. However, Canadians are not all benefiting from the creation of the Cannabis Act. There are barriers doing cannabis clinical research. Many prescribers and provincial health systems still refuse to help patients safely access medicinal cannabis despite legalization. This is just not good health care according to Dr. Lynda Balneaves. Her team set out to quantify patients’ hurdles with the Medical Cannabis Access and Experiences in Canada Study. In this episode, Kirk and Trevor explore how medical cannabis is different from recreational cannabis and how the status quo of lumping them together is just not good for patient care.

Saturday, 18 April 2020 21:24

E48 - Doctor Nurse – Lynda Balneaves

Rather than measure the wing span of mosquitoes, Dr. Lynda Balneaves RN became a nurse. Her story begins with recognizing a love for people and for travel. Her academic journey, of supporting people and health care providers with engaging in shared decision-making related to complementary and integrative health care, includes some of Canada’s earliest cannabis research. The scholastic chronicles, of this Doctor Nurse, speaks to how we can never truly plan our life path, but we do have the power to be properly prepared for opportunity. This episode will guide care givers in their practice responsibilities with cannabis, while increasing the expectations of those who receive care through it.